Eurofins DiscoverX

Eurofins DiscoverX is a leading biotechnology research company committed to enabling and accelerating multi-modality drug discovery and development, from initial discovery to QC lot release. Located in Fremont, CA 94538, US, Eurofins DiscoverX provides trusted product solutions that accelerate research and drug discovery programs with confidence, focusing on cytokine receptors, checkpoint receptors, GPCRs, kinases, ion channels, epigenetics, nuclear receptors, and other crucial target families.

Eurofins DiscoverX develops and manufactures cutting-edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for various applications, including small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, and pharmacotrafficking. These products are developed across three R&D and manufacturing centers of excellence in the San Francisco Bay Area, California (Fremont); St. Louis area, Missouri (St. Charles); and Poitiers, France.

With a strong focus on innovation and quality, Eurofins DiscoverX continues to drive advancements in biotechnology research, supporting scientists in their quest to develop new therapies and improve patient outcomes. The company’s dedication to excellence makes it a valuable partner in the drug discovery process. Eurofins DiscoverX looks forward to further growth and development in the biotechnology sector. We invite the manager of Eurofins DiscoverX to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.